JP2021505676A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505676A5 JP2021505676A5 JP2020550062A JP2020550062A JP2021505676A5 JP 2021505676 A5 JP2021505676 A5 JP 2021505676A5 JP 2020550062 A JP2020550062 A JP 2020550062A JP 2020550062 A JP2020550062 A JP 2020550062A JP 2021505676 A5 JP2021505676 A5 JP 2021505676A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024005578A JP2024041959A (ja) | 2017-12-11 | 2024-01-17 | 抗ｃｄ２２抗体－メイタンシンコンジュゲートおよびその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762597160P | 2017-12-11 | 2017-12-11 | |
| US62/597,160 | 2017-12-11 | ||
| PCT/US2018/064879 WO2019118411A2 (en) | 2017-12-11 | 2018-12-11 | Anti-cd22 antibody-maytansine conjugates, combinations, and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024005578A Division JP2024041959A (ja) | 2017-12-11 | 2024-01-17 | 抗ｃｄ２２抗体－メイタンシンコンジュゲートおよびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505676A JP2021505676A (ja) | 2021-02-18 |
| JP2021505676A5 true JP2021505676A5 (https=) | 2021-05-06 |
| JP7466455B2 JP7466455B2 (ja) | 2024-04-12 |
Family
ID=66819489
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550062A Active JP7466455B2 (ja) | 2017-12-11 | 2018-12-11 | 抗ｃｄ２２抗体－メイタンシンコンジュゲートおよびその使用方法 |
| JP2024005578A Pending JP2024041959A (ja) | 2017-12-11 | 2024-01-17 | 抗ｃｄ２２抗体－メイタンシンコンジュゲートおよびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024005578A Pending JP2024041959A (ja) | 2017-12-11 | 2024-01-17 | 抗ｃｄ２２抗体－メイタンシンコンジュゲートおよびその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20190201541A1 (https=) |
| EP (1) | EP3723763A4 (https=) |
| JP (2) | JP7466455B2 (https=) |
| KR (1) | KR20200117992A (https=) |
| CN (1) | CN111787923A (https=) |
| AU (1) | AU2018385599A1 (https=) |
| BR (1) | BR112020011445A2 (https=) |
| CA (1) | CA3082912A1 (https=) |
| EA (1) | EA202091161A1 (https=) |
| IL (1) | IL275190A (https=) |
| MX (1) | MX2020006010A (https=) |
| SG (1) | SG11202004579RA (https=) |
| WO (1) | WO2019118411A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102783230B1 (ko) | 2015-11-09 | 2025-03-19 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 항-cd22 항체-메이탄신 콘쥬게이트 및 그것의 사용 방법 |
| CA3082912A1 (en) * | 2017-12-11 | 2019-06-20 | Triphase Accelerator U.S. Corporation | Anti-cd22 antibody-maytansine conjugates, combinations, and methods of use thereof |
| KR20220079576A (ko) | 2019-10-04 | 2022-06-13 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 항-cd25 항체-메이탄신 접합체 및 이의 사용 방법 |
| WO2022068141A1 (zh) * | 2020-09-29 | 2022-04-07 | 昆明赛诺制药股份有限公司 | 人源化抗-cd22重组免疫毒素及其应用 |
| KR20230122008A (ko) * | 2020-11-20 | 2023-08-22 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 항체-약물 접합체를 위한 글리코시드 이중-절단 링커 |
| EP4301415A4 (en) * | 2021-03-03 | 2026-03-18 | Scherer Technologies Llc R P | Branched-Cell Networks for Antibody-Drug Conjugates and Their Methods of Use |
| WO2023009759A2 (en) * | 2021-07-30 | 2023-02-02 | R.P. Scherer Technologies, Llc | Antibody-drug conjugates and methods of use thereof |
| KR20240083175A (ko) * | 2021-08-25 | 2024-06-11 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 항체-약물-접합체를 사용하는 방법 |
| AU2023268538A1 (en) * | 2022-05-13 | 2024-11-21 | Exelixis, Inc. | 5t4 antibody-drug conjugates and uses thereof |
| AU2024292307A1 (en) * | 2023-07-20 | 2026-01-29 | Exelixis, Inc. | Tyrosine-protein kinase membrane receptor 1 (ror1) antibody-drug conjugates and uses thereof |
| WO2025019780A1 (en) * | 2023-07-20 | 2025-01-23 | Exelixis, Inc. | Activatable tyrosine-protein kinase membrane receptor (ror) antibody-drug conjugates and uses thereof |
| WO2025019776A2 (en) * | 2023-07-20 | 2025-01-23 | Exelixis, Inc. | Interleukin-13 receptor subunit alpha-2 antibody-drug conjugates and uses thereof |
| WO2025106658A1 (en) * | 2023-11-15 | 2025-05-22 | Exelixis, Inc. | 5t4 antibody drug conjugates and methods of their use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306393B1 (en) * | 1997-03-24 | 2001-10-23 | Immunomedics, Inc. | Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| US7097840B2 (en) * | 2000-03-16 | 2006-08-29 | Genentech, Inc. | Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
| KR20120064120A (ko) * | 2004-06-01 | 2012-06-18 | 제넨테크, 인크. | 항체 약물 접합체 및 방법 |
| CA2644906C (en) * | 2006-03-06 | 2016-05-10 | Medimmune, Inc. | Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| US9238878B2 (en) * | 2009-02-17 | 2016-01-19 | Redwood Bioscience, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
| SI2900277T1 (sl) * | 2012-12-13 | 2022-05-31 | Immunomedics, Inc. | Odmerki imunokonjugatov protiteles in SN-38 za boljšo učinkovitost in zmanjšano toksičnost |
| CN105722859B (zh) * | 2013-07-25 | 2021-05-07 | 西托姆克斯治疗公司 | 多特异性抗体、多特异性可活化抗体及其使用方法 |
| WO2015081282A1 (en) * | 2013-11-27 | 2015-06-04 | Redwood Bioscience, Inc. | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate |
| EP4257134A3 (en) * | 2015-06-25 | 2024-01-24 | Immunomedics, Inc. | Combining anti-hla-dr or anti-trop-2 antibodies with microtubule inhibitors, parp inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer |
| KR102783230B1 (ko) | 2015-11-09 | 2025-03-19 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 항-cd22 항체-메이탄신 콘쥬게이트 및 그것의 사용 방법 |
| CA3082912A1 (en) * | 2017-12-11 | 2019-06-20 | Triphase Accelerator U.S. Corporation | Anti-cd22 antibody-maytansine conjugates, combinations, and methods of use thereof |
-
2018
- 2018-12-11 CA CA3082912A patent/CA3082912A1/en active Pending
- 2018-12-11 AU AU2018385599A patent/AU2018385599A1/en not_active Abandoned
- 2018-12-11 KR KR1020207019323A patent/KR20200117992A/ko not_active Ceased
- 2018-12-11 BR BR112020011445-6A patent/BR112020011445A2/pt not_active Application Discontinuation
- 2018-12-11 WO PCT/US2018/064879 patent/WO2019118411A2/en not_active Ceased
- 2018-12-11 JP JP2020550062A patent/JP7466455B2/ja active Active
- 2018-12-11 SG SG11202004579RA patent/SG11202004579RA/en unknown
- 2018-12-11 MX MX2020006010A patent/MX2020006010A/es unknown
- 2018-12-11 US US16/216,233 patent/US20190201541A1/en not_active Abandoned
- 2018-12-11 EA EA202091161A patent/EA202091161A1/ru unknown
- 2018-12-11 EP EP18888720.2A patent/EP3723763A4/en not_active Withdrawn
- 2018-12-11 CN CN201880079401.7A patent/CN111787923A/zh active Pending
-
2020
- 2020-06-07 IL IL275190A patent/IL275190A/en unknown
-
2024
- 2024-01-17 JP JP2024005578A patent/JP2024041959A/ja active Pending